PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34659631-14	2021	Ginsenoside Rg3 may be a promising cardioprotective agent against vandetanib-induced QT interval prolongation through targeting hERG channel.	ginsenoside Rg3	0-15	ETS transcription factor ERG	Homo sapiens	128-132	
34659631-4	2021	Some studies have showed that ginsenoside Rg3 decelerated hERG K(+) channel tail current deactivation.	ginsenoside Rg3	30-45	ETS transcription factor ERG	Homo sapiens	58-62	
34659631-5	2021	Therefore, in this study, we aim to confirm whether ginsenoside Rg3 targeting hERG K(+) channel could be used to reverse the vandetanib-induced QT interval prolongation.	ginsenoside Rg3	52-67	ETS transcription factor ERG	Homo sapiens	78-82	
34659631-13	2021	Furthermore, ginsenoside Rg3 alleviated vandetanib-induced hERG current inhibition and accelerated the process of the channel activation.	ginsenoside Rg3	13-28	ETS transcription factor ERG	Homo sapiens	59-63